Lipidology, cardiovascular risk, and schizophrenia

Curr Opin Lipidol. 2016 Jun;27(3):305-7. doi: 10.1097/MOL.0000000000000307.

Authors

Leonard Kritharides¹, Kerry-Anne Rye, Tim J Lambert, Wendy Jessup

Affiliation

¹ aAtherosclerosis Laboratory, ANZAC Research Institute, University of Sydney bDepartment of Cardiology, Concord Repatriation General Hospital cLipid Research Group, School of Medical Sciences, University of New South Wales dCollaborative Centre for Cardiometabolic Health in Psychosis, Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.

PMID: 27145103
DOI: 10.1097/MOL.0000000000000307

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Coronary Disease* / etiology
Coronary Disease* / metabolism
Humans
Lipid Metabolism*
Risk Factors
Schizophrenia* / complications
Schizophrenia* / metabolism